Clinical Parameters | No.# | Nuclear Staining | P Value | Clinical Parameters | No.# | Nuclear Staining | P Value | ||
---|---|---|---|---|---|---|---|---|---|
 |  | Low positive | Strong positive |  |  |  | Low positive | Strong positive |  |
Gender | Â | Â | Â | Â | Stage | Â | Â | Â | Â |
   Male | 30 | 20 | 10 | 0.165 |    I~II | 24 | 18 | 6 | 0.582 |
   Female | 44 | 35 | 9 |  |    III~IV | 50 | 37 | 13 |  |
Age | Â | Â | Â | Â | IPI | Â | Â | Â | Â |
   < 60 | 55 | 43 | 12 | 0.161 |    0~2 | 48 | 39 | 9 | 0.099 |
   ≥ 60 | 19 | 12 | 7 |  |    3~4 | 22 | 14 | 8 |  |
B symptoms | Â | Â | Â | Â | Bulky mass | Â | Â | Â | Â |
   positive | 29 | 23 | 6 | 0.306 |    ≥ 10 cm | 9 | 6 | 3 | 0.440 |
   negative | 45 | 32 | 13 |  |    < 10 cm | 55 | 47 | 16 |  |
LDH | Â | Â | Â | Â | Molecular subtypes | Â | Â | Â | Â |
   positive | 28 | 19 | 9 | 0.235 |    GCB | 24 | 21 | 3 | 0.061 |
   negative | 46 | 36 | 10 |  |    non-GCB | 50 | 34 | 16 |  |
β2-MG |  |  |  |  | Treatment regimens |  |  |  |  |
   positive | 46 | 34 | 12 | 0.513 |    CHOP | 31 | 22 | 9 |  |
   negative | 17 | 12 | 5 |  |    R-CHOP | 27 | 19 | 8 |  |
ESR | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   positive | 38 | 28 | 10 | 0.406 |  |  |  |  |  |
   negative | 29 | 23 | 6 |  |  |  |  |  |  |